002793 罗欣药业
已收盘 05-28 15:00:00
资讯
新帖
简况
罗欣药业：2025年销售费用率已由43.11%降至40.63%
证券之星 · 05-27 11:36
罗欣药业：2025年销售费用率已由43.11%降至40.63%
股市必读：罗欣药业(002793)股东户数3.66万户，较上期减少8.79%
证券之星 · 05-25
股市必读：罗欣药业(002793)股东户数3.66万户，较上期减少8.79%
罗欣药业(002793)5月20日股东户数3.66万户，较上期减少8.79%
证券之星 · 05-22
罗欣药业(002793)5月20日股东户数3.66万户，较上期减少8.79%
罗欣药业：截止至2026年5月20日，公司股东总户数为36,577
证券之星 · 05-22
罗欣药业：截止至2026年5月20日，公司股东总户数为36,577
股市必读：罗欣药业（002793）5月21日收盘跌5.21%，主力净流出3480.87万元
证券之星 · 05-22
股市必读：罗欣药业（002793）5月21日收盘跌5.21%，主力净流出3480.87万元
注射用阿奇霉素被判为“劣药”，罗欣药业收百万罚单，公司回应
蓝鲸财经 · 05-20
注射用阿奇霉素被判为“劣药”，罗欣药业收百万罚单，公司回应
罗欣药业(002793.SZ)：控股子公司山东罗欣生产销售劣药 被罚没186.84万元
智通财经 · 05-20
罗欣药业(002793.SZ)：控股子公司山东罗欣生产销售劣药 被罚没186.84万元
罗欣药业（002793）披露2025年年度股东会决议公告，5月19日股价下跌5.84%
证券之星 · 05-19
罗欣药业（002793）披露2025年年度股东会决议公告，5月19日股价下跌5.84%
生产销售劣药，罗欣药业被罚没逾186万元，609支药品被没收
澎湃新闻 · 05-19
生产销售劣药，罗欣药业被罚没逾186万元，609支药品被没收
罗欣药业：尚未向深圳证券交易所申报注册申请文件
证券之星 · 05-19
罗欣药业：尚未向深圳证券交易所申报注册申请文件
罗欣药业：截止至2026年5月8日，公司股东总户数为40,103
证券之星 · 05-14
罗欣药业：截止至2026年5月8日，公司股东总户数为40,103
股市必读：罗欣药业(002793)股东户数4.01万户，较上期减少5.74%
证券之星 · 05-14
股市必读：罗欣药业(002793)股东户数4.01万户，较上期减少5.74%
罗欣药业（002793）披露将举行2025年度网上业绩说明会，5月13日股价下跌0.37%
证券之星 · 05-13
罗欣药业（002793）披露将举行2025年度网上业绩说明会，5月13日股价下跌0.37%
罗欣药业：公司最新一期（2026年5月8日）股东总户数为40,103
证券之星 · 05-13
罗欣药业：公司最新一期（2026年5月8日）股东总户数为40,103
罗欣药业：截止至2026年4月30日，公司股东总户数为42,547
证券之星 · 05-06
罗欣药业：截止至2026年4月30日，公司股东总户数为42,547
罗欣药业：截止至2026年4月20日，公司股东总户数为34,749
证券之星 · 04-27
罗欣药业：截止至2026年4月20日，公司股东总户数为34,749
4月23日罗欣药业现4085.05万元大宗交易
证券之星 · 04-23
4月23日罗欣药业现4085.05万元大宗交易
罗欣药业：公司正推进降本增效、聚焦主业优化结构
证券之星 · 04-23
罗欣药业：公司正推进降本增效、聚焦主业优化结构
罗欣药业最新公告：第一季度净利润同比增长327.35%
证券之星 · 04-22
罗欣药业最新公告：第一季度净利润同比增长327.35%
罗欣药业：截止至2026年4月10日，公司股东总户数为35,630
证券之星 · 04-14
罗欣药业：截止至2026年4月10日，公司股东总户数为35,630
暂无数据
公司概况
公司名称：
罗欣药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2016-04-15
主营业务：
罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产与销售。公司的主要产品是消化系统类、抗生素类、呼吸系统类、其他类、代理产品。
发行价格：
11.97
{"stockData":{"symbol":"002793","market":"SZ","secType":"STK","nameCN":"罗欣药业","latestPrice":4.27,"timestamp":1779951816000,"preClose":4.27,"halted":0,"volume":16745960,"delay":0,"changeRate":0,"floatShares":1086000000,"shares":1088000000,"eps":-0.2484,"marketStatus":"已收盘","change":0,"latestTime":"05-28 15:00:00","open":4.27,"high":4.31,"low":4.2,"amount":71218000,"amplitude":0.0258,"askPrice":4.28,"askSize":172,"bidPrice":4.27,"bidSize":422,"shortable":0,"etf":0,"ttmEps":-0.2484,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780018200000},"marketStatusCode":5,"adr":0,"adjPreClose":4.27,"symbolType":"stock","openAndCloseTimeList":[[1779931800000,1779939000000],[1779944400000,1779951600000]],"highLimit":4.7,"lowLimit":3.84,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1087588486,"isCdr":false,"pbRate":4.22,"roa":"--","roe":"2.11%","epsLYR":-0.2718,"committee":-0.348931,"marketValue":4644000000,"turnoverRate":0.0154,"status":2,"floatMarketCap":4637000000},"requestUrl":"/m/hq/s/002793/tweets","defaultTab":"tweets","newsList":[{"id":"2638573510","title":"罗欣药业：2025年销售费用率已由43.11%降至40.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638573510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638573510?lang=zh_cn&edition=full","pubTime":"2026-05-27 11:36","pubTimestamp":1779852984,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业05月26日在投资者关系平台上答复投资者关心的问题。公司销售费用主要用于公司核心创新药产品替戈拉生片上市之后的学术推广与渠道建设，同时包含前期业务调整、团队搭建的阶段性投入。目前泰欣赞三大适应症已全部纳入医保，规模效应逐步显现，2025 年销售费用率已由 43.11% 降至 40.63%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700019914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0132","BK0239","BK0001","08058"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638130304","title":"股市必读：罗欣药业(002793)股东户数3.66万户，较上期减少8.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638130304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638130304?lang=zh_cn&edition=full","pubTime":"2026-05-25 02:13","pubTimestamp":1779646389,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，罗欣药业报收于4.5元，下跌1.1%，换手率2.29%，成交量24.89万手，成交额1.12亿元。当日关注点来自交易信息汇总：5月22日主力资金净流出1119.06万元，散户资金净流入1605.71万元。股本股东变化股东户数变动近日罗欣药业披露，截至2026年5月20日公司股东户数为3.66万户，较5月8日减少3526.0户，减幅为8.79%。户均持股数量由上期的2.71万股增加至2.97万股，户均持股市值为14.27万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500000931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","08058","BK0132","BK0239","002793","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637390968","title":"罗欣药业(002793)5月20日股东户数3.66万户，较上期减少8.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637390968","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637390968?lang=zh_cn&edition=full","pubTime":"2026-05-22 17:30","pubTimestamp":1779442232,"startTime":"0","endTime":"0","summary":"证券之星消息，近日罗欣药业披露，截至2026年5月20日公司股东户数为3.66万户，较5月8日减少3526.0户，减幅为8.79%。在化学制药行业个股中，罗欣药业股东户数高于行业平均水平，截至5月20日，化学制药行业平均股东户数为3.58万户。从股价来看，2026年5月8日至2026年5月20日，罗欣药业区间跌幅为12.41%，在此期间股东户数减少3526.0户，减幅为8.79%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200032403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0001","BK0239","BK0132","002793","08058"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637336201","title":"罗欣药业：截止至2026年5月20日，公司股东总户数为36,577","url":"https://stock-news.laohu8.com/highlight/detail?id=2637336201","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637336201?lang=zh_cn&edition=full","pubTime":"2026-05-22 11:36","pubTimestamp":1779420972,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)05月21日在投资者关系平台上答复投资者关心的问题。投资者提问：您好！请问贵公司截至2026年5月20日收盘的股东人数?罗欣药业回复：尊敬的投资者，您好！截止至2026年5月20日，公司股东总户数为36,577。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200019391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","08058","BK0201","002793","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637355685","title":"股市必读：罗欣药业（002793）5月21日收盘跌5.21%，主力净流出3480.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637355685","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637355685?lang=zh_cn&edition=full","pubTime":"2026-05-22 01:31","pubTimestamp":1779384668,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，罗欣药业报收于4.55元，下跌5.21%，换手率2.94%，成交量31.97万手，成交额1.5亿元。当日关注点来自交易信息汇总：罗欣药业股价连续7日下跌，近5个交易日中2日跌幅超5%，5月21日收跌5.21%报4.55元。来自交易信息汇总：主力资金前10个交易日累计净流出1.69亿元，当日主力净流出3480.87万元，散户资金积极进场。该股最近90天内获2家机构评级，其中买入评级1家，增持评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200002294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","08058","BK0201","BK0132","BK0001","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636815458","title":"注射用阿奇霉素被判为“劣药”，罗欣药业收百万罚单，公司回应","url":"https://stock-news.laohu8.com/highlight/detail?id=2636815458","media":"蓝鲸财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636815458?lang=zh_cn&edition=full","pubTime":"2026-05-20 14:30","pubTimestamp":1779258646,"startTime":"0","endTime":"0","summary":"早在5月18日，山东省药监局发布的行政处罚信息显示，罗欣药业因生产销售不符合国家药品标准的注射用阿奇霉素，被处以没收药品609支、没收违法所得6.8万元并处罚款180万元，罚没款合计186.84万元。罗欣药业表示，经全面排查，该批次产品未收到任何药品不良反应案例或患者投诉。罗欣药业在公告中表示，本次事件为偶发独立事件。国家药监局数据显示，目前，注射用阿奇霉素批准文号已达138条。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1779258407133161330","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0201","BK0239","08058","BK0132","BK0001","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636893386","title":"罗欣药业(002793.SZ)：控股子公司山东罗欣生产销售劣药 被罚没186.84万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2636893386","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636893386?lang=zh_cn&edition=full","pubTime":"2026-05-20 08:02","pubTimestamp":1779235344,"startTime":"0","endTime":"0","summary":"山东省药品监督管理局依法对山东罗欣作出行政处罚，罚没款合计186.84万元。山东罗欣生产的注射用阿奇霉素2024年度营业收入2,263.00万元，占公司2024年度营业收入的0.85%;2025年度营业收入236.28万元，占公司2025年度营业收入的0.10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443717.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"罗欣药业(002793.SZ)：控股子公司山东罗欣生产销售劣药 被罚没186.84万元","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","08058","002793","BK0239","BK0001","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636349138","title":"罗欣药业（002793）披露2025年年度股东会决议公告，5月19日股价下跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636349138","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636349138?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:27","pubTimestamp":1779182826,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，罗欣药业报收于4.68元，较前一交易日下跌5.84%，最新总市值为50.9亿元。该股当日开盘4.97元，最高5.0元，最低4.51元，成交额达2.22亿元，换手率为4.33%。公告显示，公司于2026年5月18日召开2025年年度股东会，审议通过了包括2025年度董事会工作报告、利润分配预案、续聘审计机构、日常关联交易确认与预计、董事薪酬管理制度修订、2026年度授信及对外担保等多项议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900031376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","08058","BK0201","002793","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636889595","title":"生产销售劣药，罗欣药业被罚没逾186万元，609支药品被没收","url":"https://stock-news.laohu8.com/highlight/detail?id=2636889595","media":"澎湃新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636889595?lang=zh_cn&edition=full","pubTime":"2026-05-19 10:29","pubTimestamp":1779157740,"startTime":"0","endTime":"0","summary":"又要上市药企被处罚！ 5月18日，山东省药品监督管理局发布的行政处罚信息显示，山东罗欣药业（维权）集团股份有限公司因生产销售不符合国家药品标准规定的注射用阿奇霉素，被没收药品609支，没收违法所得68442.48元，并处罚款180万元，罚没款合计186.84万元，处罚决定日期为2026年4月20日。 罚单在违法事实中提到，罗欣药业的相关行为违反了《中华人民共和国药品管理法》第九十八条第一款。 截至发稿时，罗欣药业跌超4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2026-05-19/doc-inhykxfn3331772.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-05-19/doc-inhykxfn3331772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0001","002793","BK0201","08058","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636888587","title":"罗欣药业：尚未向深圳证券交易所申报注册申请文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2636888587","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636888587?lang=zh_cn&edition=full","pubTime":"2026-05-19 08:45","pubTimestamp":1779151511,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘定增方案是否已经向深圳证监会提起申请注册？罗欣药业回复：尊敬的投资者您好！公司2025年度向特定对象发行A股股票事项，截至目前，相关工作正按计划有序推进，尚未向深圳证券交易所申报注册申请文件。后续进展，公司将严格按照信息披露规则，及时在指定媒体发布公告。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900009187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","399001","08058","BK0001","BK0132","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635769437","title":"罗欣药业：截止至2026年5月8日，公司股东总户数为40,103","url":"https://stock-news.laohu8.com/highlight/detail?id=2635769437","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635769437?lang=zh_cn&edition=full","pubTime":"2026-05-14 11:37","pubTimestamp":1778729841,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，董秘秘截止到5月8号股东有多少人？罗欣药业回复：尊敬的投资者，您好！截止至2026年5月8日，公司股东总户数为40,103。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400018425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","002793","BK0001","BK0239","BK0132","08058"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635730730","title":"股市必读：罗欣药业(002793)股东户数4.01万户，较上期减少5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635730730","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635730730?lang=zh_cn&edition=full","pubTime":"2026-05-14 03:44","pubTimestamp":1778701452,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，罗欣药业报收于5.38元，下跌0.37%，换手率3.4%，成交量36.87万手，成交额2.0亿元。来自股本股东变化：截至5月8日股东户数环比下降5.74%，户均持股增至2.71万股，呈现筹码集中迹象。股本股东变化股东户数变动截至2026年5月8日，公司股东户数为4.01万户，较4月30日减少2444.0户，减幅为5.74%。户均持股数量由上期的2.56万股上升至2.71万股，户均持股市值为14.86万元。问题征集截止时间为2026年5月15日12:00。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400004067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0239","BK0001","BK0132","002793","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635783103","title":"罗欣药业（002793）披露将举行2025年度网上业绩说明会，5月13日股价下跌0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635783103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635783103?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:31","pubTimestamp":1778668314,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，罗欣药业报收于5.38元，较前一交易日下跌0.37%，最新总市值为58.51亿元。该股当日开盘5.41元，最高5.58元，最低5.35元，成交额达2亿元，换手率为3.4%。罗欣药业于近日披露《关于参加2026年山东辖区上市公司投资者网上集体接待日活动暨2025年度网上业绩说明会的公告》。问题征集截止时间为2026年5月15日12:00。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300034678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0132","BK0239","002793","08058","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635273737","title":"罗欣药业：公司最新一期（2026年5月8日）股东总户数为40,103","url":"https://stock-news.laohu8.com/highlight/detail?id=2635273737","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635273737?lang=zh_cn&edition=full","pubTime":"2026-05-13 11:33","pubTimestamp":1778643204,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)05月12日在投资者关系平台上答复投资者关心的问题。投资者提问：请问2026年5月10日公司股东人数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！公司最新一期（2026年5月8日）股东总户数为40,103。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300017659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0132","BK0201","BK0001","BK0239","08058"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633902296","title":"罗欣药业：截止至2026年4月30日，公司股东总户数为42,547","url":"https://stock-news.laohu8.com/highlight/detail?id=2633902296","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633902296?lang=zh_cn&edition=full","pubTime":"2026-05-06 15:57","pubTimestamp":1778054236,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)05月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年4月30日公司的股东总数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！截止至2026年4月30日，公司股东总户数为42,547。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600021449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793","BK0001","BK0201","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630365536","title":"罗欣药业：截止至2026年4月20日，公司股东总户数为34,749","url":"https://stock-news.laohu8.com/highlight/detail?id=2630365536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630365536?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:06","pubTimestamp":1777277167,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止至2026年4月20日 股东人数是多少罗欣药业回复：尊敬的投资者，您好！截止至2026年4月20日，公司股东总户数为34,749。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700027228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","08058","BK0201","BK0132","BK0001","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629388145","title":"4月23日罗欣药业现4085.05万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2629388145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629388145?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:20","pubTimestamp":1776936053,"startTime":"0","endTime":"0","summary":"证券之星消息，4月23日罗欣药业发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交7.4万手，折价成交2笔。该股近期无解禁股上市。截至2026年4月23日收盘，罗欣药业(002793)报收于5.63元，上涨9.96%，涨停，换手率4.63%，成交量50.23万手，成交额2.76亿元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300047313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0239","08058","BK0132","BK0001"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629056790","title":"罗欣药业：公司正推进降本增效、聚焦主业优化结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2629056790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629056790?lang=zh_cn&edition=full","pubTime":"2026-04-23 11:36","pubTimestamp":1776915393,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)04月23日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好公司连续四年亏损；是否有降本增效办法；比如是否裁员呢罗欣药业回复：尊敬的投资者您好！公司正推进降本增效、聚焦主业优化结构，人员随业务合理调整，核心团队稳定，全力改善经营业绩。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300031546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0239","002793","08058","BK0132","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629104318","title":"罗欣药业最新公告：第一季度净利润同比增长327.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629104318","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629104318?lang=zh_cn&edition=full","pubTime":"2026-04-22 19:31","pubTimestamp":1776857488,"startTime":"0","endTime":"0","summary":"罗欣药业(002793.SZ)公告称，2026年第一季度实现营业收入5.83亿元，同比增长20.72%；归属于上市公司股东的净利润为2415.01万元，同比增长327.35%。业绩变动主要系核心创新药替戈拉生片市场覆盖率与终端动销水平持续提升，产品结构优化带动综合毛利率显著改善，以及处置罗欣安若维他部分股权形成投资收益所致。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200047771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","002793"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627249606","title":"罗欣药业：截止至2026年4月10日，公司股东总户数为35,630","url":"https://stock-news.laohu8.com/highlight/detail?id=2627249606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627249606?lang=zh_cn&edition=full","pubTime":"2026-04-14 11:34","pubTimestamp":1776137698,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)04月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年4月10日公司股东人数是多少？谢谢！罗欣药业回复：尊敬的投资者，您好！截止至2026年4月10日，公司股东总户数为35,630。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400016045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0201","BK0001","BK0239","BK0132","08058"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779987395886,"stockEarnings":[{"period":"1week","weight":-0.0615},{"period":"1month","weight":-0.225},{"period":"3month","weight":-0.1339},{"period":"6month","weight":-0.2107},{"period":"1year","weight":-0.0339},{"period":"ytd","weight":-0.1104}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.0049},{"period":"3month","weight":-0.0154},{"period":"6month","weight":0.054},{"period":"1year","weight":0.2272},{"period":"ytd","weight":0.0327}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"罗欣药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36577人(较上一季度减少8.79%)","perCapita":"29688股","listingDate":"2016-04-15","address":"山东省临沂市罗庄区罗七路18号4号楼","registeredCapital":"108758万元","survey":" 罗欣药业集团股份有限公司的主营业务是医药产品的研发、生产与销售。公司的主要产品是消化系统类、抗生素类、呼吸系统类、其他类、代理产品。","listedPrice":11.97},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,002793,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}